Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor

Journal of Endocrinology

Volumn 175, Issue 2, 2002, Pages 425-434

  Kovacs, M ^a,b   Schally, A V ^a,b   Lee, E J ^c   Busto, R ^a,b   Armatis, P ^a   Groot, K ^a   Varga, J L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC AMP; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR ANTAGONIST; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; HORMONE ANTAGONIST; JV 1 36; JV 1 38; MESSENGER RNA; PROLACTIN; SERMORELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL CULTURE; CELL LEVEL; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENCY; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE INHIBITION; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PERFUSION AND SUPERFUSION; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TIME; TUMOR CELL LINE;

ANIMALS; CYCLIC AMP; GENE EXPRESSION; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; PITUITARY GLAND; PROLACTIN; RATS; RECEPTORS, SOMATOTROPIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036855810     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1750425     Document Type: Review

References (39)

1. Bancroft FC, Levine L & Tashjian AH Jr 1969 Control of growth hormone production by a clonal strain of rat pituitary cells. Stimulation by hydrocortisone. Journal of Cell Biology 43 432-441.
2. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH & Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 563-566.
3. Clark RG & Robinson ICAF 1985 Growth induced by pulsatile infusion of an amidated fragment of growth hormone-releasing factor in normal and GHRF-deficient rats. Nature 314 281-283.
4. Csernus VJ & Schally AV 1991 The dispersed cell superfusion system. In Neuroendocrine Research Methods, pp 71-109. Ed BD Greenstein. London: Harwood Academic Publishers.
5. Csernus VJ, Schally AV & Groot K 1999 Antagonistic analogs of growth hormone-releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro. Peptides 20 843-850.
6. Halmos G, Schally AV, Varga JL, Plonowski A, Rekasi Z & Czompoly T 2000 Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. PNAS 97 10555-10560.
7. Halmos G, Schally AV, Czompoly T, Krupa M, Varga JL & Rekasi Z 2002 Expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human prostate cancer. Journal of Clinical Endocrinology and Metabolism (In Press).
8. Horvath J, Groot K & Schally AV 1995 Growth hormone-releasing hormone stimulates cAMP release in superfused rat pituitary cells. PNAS 92 1856-1860.
9. Jaffe CA, DeMott-Friberg R, Frohman LA & Barkan AL 1997 Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist Journal of Clinical Endocrinology and Metabolism 82 634-637.
10. Kahan Z, Arencibia J, Csernus V, Groot K, Kineman R, Robinson WR & Schally AV 1999 Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. Journal of Clinical Endocrinology and Metabolism 84 582-589.
11. Kahan Z, Varga JL, Schally AV, Rekasi Z, Armatis P, Chatzistamou I, Czompoly T & Halmos G 2000 Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice. Breast Cancer Research and Treatment 60 71-79.
12. Kiaris H, Schally AV, Varga JL, Groot K & Armatis P 1999 Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma. PNAS 96 14894-14898.
13. Kiaris H, Schally AV, Busto R, Halmos G, Artavanis-Tsakonas S & Varga JL 2002 Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. PNAS 99 196-200.
14. 2 on the GH release in rat. Neuroendocrinology 59 371-379.
15. Kovacs M, Zarandi M, Halmos G, Groot K & Schally AV 1996 Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action. Endocrinology 137 5364-5369.
16. Kovacs M, Kineman RD, Schally AV, Zarandi M, Groot K & Frohman LA 1997a Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor-I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly. Endocrinology 138 4536-4542.
17. Kovacs M, Schally AV, Zarandi M & Groot K 1997b Inhibition of GH release in rats by new potent antagonists of growth hormone-releasing hormone (GH-RH). Peptides 18 431-438.
18. Kovacs M, Schally AV, Csernus B, Busto R, Rekasi Z & Nagy A 2002 Targeted cytotoxic analogue of lutenizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH. Journal of Neuroendocrinology 14 5-13.
19. Lamharzi N, Schally AV, Koppan AV, Koppan M & Groot K 1998 Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the level and mRNA expression of insulin like growth factor II in tumors. PNAS 95 8864-8868.
20. Lee EJ, Anderson LM, Thimmapaya B & Jameson JL 1999 Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenoviral-mediated gene therapy of pituitary tumors. Journal of Clinical Endocrinology and Metabolism 84 786-794.
21. Lee EJ, Duan R, Kotlar T & Jameson JL 2001 Restoration of growth hormone-releasing hormone (GHRH) responsiveness in pituitary GH3 cells by adenovirus-directed expression of the human GHRH receptor. Endocrinology 142 414-420.
22. Mayo KE 1992 Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Molecular Endocrinology 6 1734-1744.
23. Mayo KE, Hammer RE, Swanson JW, Brinster RL, Rosenfeld MG & Evans RM 1988 Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Molecular Endocrinology 2 606-612.
24. Mayo KE, Godfrey PA, Suhr ST, Kulik DJ & Rahal JO 1995 Growth hormone-releasing hormone. Synthesis and signaling. In Recent Progress in Hormone Research, pp 35-73. Ed. CW Bardin. San Diego, CA: Academic Press.
25. Pinski J, Schally AV, Groot K, Halmos G, Szepeshazi K, Zarandi M & Armatis P 1995 Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. Journal of the National Cancer Institute 87 1787-1794.
26. Rekasi Z, Czompoly T, Schally AV & Halmos G 2000a Isolation and sequencing of cDNAs for spice variants of growth hormone-releasing hormone receptors from human cancers. PNAS 97 10561-10566.
27. Rekasi Z, Varga JL, Schally AV, Halmos G, Armatis P, Groot K & Czompoly T 2000b Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies in human prostatic and pancreatic cancers. Endocrinology 141 2120-2128.
28. Rekasi Z, Varga JL, Schally AV, Plonowski A, Halmos G, Csernus B, Armatis P & Groot K 2001 Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways. Peptides 22 879-886.
29. 2 as a GRF antagonist on membranes. Endocrinology 117 1759-1764.
30. Schally AV & Varga JL 1999 Antagonistic analogs of growth hormone-releasing hormone: new potential antitumor agents. Trends in Endocrinology and Metabolism 10 383-391.
31. Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL & Halmos G 2001 Hypothalamic hormones and cancer. Frontiers in Neuroendocrinology 22 248-291.
32. Stachura ME 1982 Sequestration of an early-release pool of growth hormone and prolactin in GH3 rat pituitary tumor cells. Endocrinology 111 1769-1777.
33. Szepeshazi K, Schally AV, Groot K, Armatis P, Halmos G, Hebert F, Szende B, Varga JL & Zarandi M 2000a Antagonists of growth hormone-releasing hormone (GHRH) decrease IGF-II production of HT-29 human colon cancer cells and inhibit tumor growth. British Journal of Cancer 82 1724-1731.
34. Szepeshazi K, Schally AV, Groot K, Armatis P, Hebert F & Halmos G 2000b Antagonists of growth hormone-releasing hormone (GHRH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumors. European Journal of Cancer 36 128-136.
35. Thorner MO, Reschke J, Chitwood J, Rogol AD, Furlanetto R, Rivier J, Vale V & Blizzard RM 1985 Acceleration of growth in two children treated with human growth hormone-releasing factor. New England Journal of Medicine 312 4-9.
36. Varga JL, Schally AV, Csernus JV, Zarandi M, Halmos G, Groot K & Rekasi Z 1999 Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. PNAS 96 692-697.
37. Wivel MM, Gao GP & Wilson JM 1999 Adenoviral vectors. In The Development of Human Gene Therapy, pp 87-110. Ed. T Friedman. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
38. Ying C, Lin DH, Sarkar DK & Chen TT 1999 Interaction between estrogen receptor and Pit-1 protein is influenced by estrogen in pituitary cells. Journal of Steroid Biochemistry and Molecular Biology 68 145-152.
39. Zhang K, Kulig E, Jin L & Lloyd RV 1993 Effects of estrogen and epidermal growth factor on prolactin and Pit-1 mRNA in GH3 cells. Proceedings of the Sociery for Experimental Biology and Medicine 202 193-200.